Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 21, 2019
United States Valuation of EQ-5D-5L Health States Using an International Protocol
A Simon Pickard, Ernest H Law, Ruixuan Jiang, et al.
Peerj
|
March 3, 2025
Deep-learning tool for early identification of non-traumatic intracranial hemorrhage etiology and application in clinical diagnostics based on computed tomography (CT) scans
Meng Zhao, Wenjie Li, Yifan Hu, et al.
Journal of Medical Economics
|
March 13, 2025
Number needed to treat (NNT) with pembrolizumab as an adjuvant therapy in resected patients with high-risk stage II (IIB and IIC) melanoma and its application to cost of preventing an event (COPE) in Mexico
Victoria Wurcel, Mónica Rojas Rojas, Juan Urrego-Reyes, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
January 7, 2025
Buried Interface Modulation Using Self-Assembled Monolayer and Ionic Liquid Hybrids for High-Performance Perovskite and Perovskite/CuInGaSe<sub>2</sub> Tandem Photovoltaics
Zihao Feng, Xinxing Liu, Ting Tian, et al.
Nature Communications
|
January 3, 2026
Crystallization modulation for wide-bandgap perovskites with universal defect passivation toward efficient perovskite/organic tandem photovoltaics
Ruixuan Jiang, Yikai Yun, Kexuan Sun, et al.
Nature Communications
|
December 10, 2025
Efficient perovskite/Cu(In,Ga)Se<sub>2</sub> tandem solar cells with a composite intermediate recombination layer
Wang Li, Junjun Zhang, Li Zeng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 6, 2022
Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
Muhammad A Khattak, Jason J Luke, Georgina V Long, et al.
Cancers
|
April 12, 2022
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
Peter Mohr, Emilie Scherrer, Chalid Assaf, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study
Elizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 21, 2019
United States Valuation of EQ-5D-5L Health States Using an International Protocol
A Simon Pickard, Ernest H Law, Ruixuan Jiang, et al.
Peerj
|
March 3, 2025
Deep-learning tool for early identification of non-traumatic intracranial hemorrhage etiology and application in clinical diagnostics based on computed tomography (CT) scans
Meng Zhao, Wenjie Li, Yifan Hu, et al.
Journal of Medical Economics
|
March 13, 2025
Number needed to treat (NNT) with pembrolizumab as an adjuvant therapy in resected patients with high-risk stage II (IIB and IIC) melanoma and its application to cost of preventing an event (COPE) in Mexico
Victoria Wurcel, Mónica Rojas Rojas, Juan Urrego-Reyes, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
January 7, 2025
Buried Interface Modulation Using Self-Assembled Monolayer and Ionic Liquid Hybrids for High-Performance Perovskite and Perovskite/CuInGaSe<sub>2</sub> Tandem Photovoltaics
Zihao Feng, Xinxing Liu, Ting Tian, et al.
Nature Communications
|
January 3, 2026
Crystallization modulation for wide-bandgap perovskites with universal defect passivation toward efficient perovskite/organic tandem photovoltaics
Ruixuan Jiang, Yikai Yun, Kexuan Sun, et al.
Nature Communications
|
December 10, 2025
Efficient perovskite/Cu(In,Ga)Se<sub>2</sub> tandem solar cells with a composite intermediate recombination layer
Wang Li, Junjun Zhang, Li Zeng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 6, 2022
Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
Muhammad A Khattak, Jason J Luke, Georgina V Long, et al.
Cancers
|
April 12, 2022
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
Peter Mohr, Emilie Scherrer, Chalid Assaf, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study
Elizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
Page
of 6